Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries

Bente Glintborg; Stylianos Georgiadis; Anne Gitte Loft; Asta Linauskas; Hanne Lindegaard; Oliver Hendricks; Dorte V Jensen; Birgitte Lange Andersen; Kamilla Danebod; Anders Villumsen; Grith Eng; Charlotte Wiell; Natalia Manilo; Salome Kristensen; Johnny Raun; Jolanta Grydehøj; Stavros Chrysidis; Mette Nørgaard; Frank Mehnert; Niels Steen Krogh; Merete Lund Hetland

doi:10.1136/annrheumdis-2019-216702

Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries

Bente Glintborg, Stylianos Georgiadis, Anne Gitte Loft, Asta Linauskas, Hanne Lindegaard, Oliver Hendricks, Dorte V Jensen, Birgitte Lange Andersen, Kamilla Danebod, Anders Villumsen, Grith Eng, Charlotte Wiell, Natalia Manilo, Salome Kristensen, Johnny Raun, Jolanta Grydehøj, Stavros Chrysidis, Mette Nørgaard, Frank Mehnert, Niels Steen KroghMerete Lund Hetland

Original language	English
Journal	Annals of the Rheumatic Diseases
Volume	79
Issue number	6
Pages (from-to)	846-848
Number of pages	3
ISSN	0003-4967
DOIs	https://doi.org/10.1136/annrheumdis-2019-216702
Publication status	Published - 2020

Keywords

Adult
Aged
Ambulatory Care/statistics & numerical data
Anti-Inflammatory Agents, Non-Steroidal/adverse effects
Arthritis/drug therapy
Biliary Tract Diseases/epidemiology
Biosimilar Pharmaceuticals/adverse effects
Chemical and Drug Induced Liver Injury/epidemiology
Cohort Studies
Denmark/epidemiology
Etanercept/adverse effects
Female
Hospitalization/statistics & numerical data
Humans
Incidence
Male
Medical Record Linkage
Middle Aged
Registries

Access to Document

10.1136/annrheumdis-2019-216702

Cite this

Glintborg, B., Georgiadis, S., Loft, A. G., Linauskas, A., Lindegaard, H., Hendricks, O., Jensen, D. V., Andersen, B. L., Danebod, K., Villumsen, A., Eng, G., Wiell, C., Manilo, N., Kristensen, S., Raun, J., Grydehøj, J., Chrysidis, S., Nørgaard, M., Mehnert, F., ... Hetland, M. L. (2020). Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries. Annals of the Rheumatic Diseases, 79(6), 846-848. https://doi.org/10.1136/annrheumdis-2019-216702

Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries. / Glintborg, Bente ; Georgiadis, Stylianos; Loft, Anne Gitte et al.
In: Annals of the Rheumatic Diseases, Vol. 79, No. 6, 2020, p. 846-848.

Research output: Contribution to journal › Letter › peer-review

Glintborg, B , Georgiadis, S, Loft, AG, Linauskas, A, Lindegaard, H, Hendricks, O, Jensen, DV, Andersen, BL, Danebod, K, Villumsen, A, Eng, G, Wiell, C, Manilo, N, Kristensen, S, Raun, J, Grydehøj, J, Chrysidis, S, Nørgaard, M, Mehnert, F, Krogh, NS & Hetland, ML 2020, 'Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries', Annals of the Rheumatic Diseases, vol. 79, no. 6, pp. 846-848. https://doi.org/10.1136/annrheumdis-2019-216702

Glintborg B , Georgiadis S, Loft AG, Linauskas A, Lindegaard H, Hendricks O et al. Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries. Annals of the Rheumatic Diseases. 2020;79(6):846-848. doi: 10.1136/annrheumdis-2019-216702

Glintborg, Bente ; Georgiadis, Stylianos ; Loft, Anne Gitte et al. / Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4) : an observational nationwide study applying linkage between DANBIO and national registries. In: Annals of the Rheumatic Diseases. 2020 ; Vol. 79, No. 6. pp. 846-848.

@article{b837bc1a35f144cfae1adc8649bb6c1c,

title = "Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries",

keywords = "Adult, Aged, Ambulatory Care/statistics & numerical data, Anti-Inflammatory Agents, Non-Steroidal/adverse effects, Arthritis/drug therapy, Biliary Tract Diseases/epidemiology, Biosimilar Pharmaceuticals/adverse effects, Chemical and Drug Induced Liver Injury/epidemiology, Cohort Studies, Denmark/epidemiology, Etanercept/adverse effects, Female, Hospitalization/statistics & numerical data, Humans, Incidence, Male, Medical Record Linkage, Middle Aged, Registries",

author = "Bente Glintborg and Stylianos Georgiadis and Loft, {Anne Gitte} and Asta Linauskas and Hanne Lindegaard and Oliver Hendricks and Jensen, {Dorte V} and Andersen, {Birgitte Lange} and Kamilla Danebod and Anders Villumsen and Grith Eng and Charlotte Wiell and Natalia Manilo and Salome Kristensen and Johnny Raun and Jolanta Grydeh{\o}j and Stavros Chrysidis and Mette N{\o}rgaard and Frank Mehnert and Krogh, {Niels Steen} and Hetland, {Merete Lund}",

note = "COPECARE",

year = "2020",

doi = "10.1136/annrheumdis-2019-216702",

language = "English",

volume = "79",

pages = "846--848",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "6",

}

TY - JOUR

T1 - Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4)

T2 - an observational nationwide study applying linkage between DANBIO and national registries

AU - Glintborg, Bente

AU - Georgiadis, Stylianos

AU - Loft, Anne Gitte

AU - Linauskas, Asta

AU - Lindegaard, Hanne

AU - Hendricks, Oliver

AU - Jensen, Dorte V

AU - Andersen, Birgitte Lange

AU - Danebod, Kamilla

AU - Villumsen, Anders

AU - Eng, Grith

AU - Wiell, Charlotte

AU - Manilo, Natalia

AU - Kristensen, Salome

AU - Raun, Johnny

AU - Grydehøj, Jolanta

AU - Chrysidis, Stavros

AU - Nørgaard, Mette

AU - Mehnert, Frank

AU - Krogh, Niels Steen

AU - Hetland, Merete Lund

N1 - COPECARE

PY - 2020

Y1 - 2020

KW - Adult

KW - Aged

KW - Ambulatory Care/statistics & numerical data

KW - Anti-Inflammatory Agents, Non-Steroidal/adverse effects

KW - Arthritis/drug therapy

KW - Biliary Tract Diseases/epidemiology

KW - Biosimilar Pharmaceuticals/adverse effects

KW - Chemical and Drug Induced Liver Injury/epidemiology

KW - Cohort Studies

KW - Denmark/epidemiology

KW - Etanercept/adverse effects

KW - Female

KW - Hospitalization/statistics & numerical data

KW - Humans

KW - Incidence

KW - Male

KW - Medical Record Linkage

KW - Middle Aged

KW - Registries

U2 - 10.1136/annrheumdis-2019-216702

DO - 10.1136/annrheumdis-2019-216702

M3 - Letter

C2 - 32111583

SN - 0003-4967

VL - 79

SP - 846

EP - 848

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 6

ER -